Dara Aliff, DO
Obstetrics & Gynecology · Charleston, WVNPI 1841270709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.
Across 143 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$542
- Astellas Pharma US Inc$357
- Pfizer$332
- Sage Therapeutics, LLC$270
- Organon$199
- Mayne Pharma Commercial LLC$198
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,86196%
- Education$1284%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $542 |
| Astellas Pharma US Inc | 14 | $357 |
| Pfizer | 20 | $332 |
| Sage Therapeutics, LLC | 13 | $270 |
| Organon | 11 | $199 |
| Mayne Pharma Commercial LLC | 2 | $198 |
| Exeltis, USA Inc. | 9 | $145 |
| Biogen | 1 | $120 |
| Myovant Sciences Inc. | 6 | $114 |
| Avion Pharmaceuticals | 7 | $94 |
| Merck | 5 | $88 |
| Mallinckrodt Enterprises LLC | 1 | $83 |
| Johnson & Johnson | 3 | $83 |
| Hologic Sales And Service, LLC | 4 | $80 |
| Bayer | 3 | $73 |
| Smith+Nephew | 3 | $51 |
| Sumitomo Pharma America, Inc. | 3 | $46 |
| Agile Therapeutics, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $15 |
| Acessa Health Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zurzuvae$120
How this compares
$2,990 in reported general payments places this provider in the 75th percentile of 172 obstetrics & gynecology providers in West Virginia.
See all obstetrics & gynecology providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $3,260 |
| Clobetasol Propionate | 11 | $161 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Charleston
- Stephen BushCharleston$33K
- Paul DietzCharleston$14K
- David PattonCharleston$12K
- Scott NaegeleCharleston$8K
- Michael LaoCharleston$7K
- David ThomasCharleston$7K
- Paul HunterCharleston$6K
- Karinna AndrewsCharleston$3K
- Megan HarrisonCharleston$2K
- Michaela KesslerCharleston$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.